Mayer-Hamblett, Nicole <br/><br/>
Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial.  [electronic resource] 

 -  American journal of respiratory and critical care medicine  11 2018 
 - 1177-1187 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1535-4970 
<br/><br/><label>Standard No.: </label>10.1164/rccm.201802-0215OC  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Adolescent<br/>Anti-Bacterial Agents--therapeutic use<br/>Azithromycin--therapeutic use<br/>Child<br/>Child, Preschool<br/>Cystic Fibrosis--complications<br/>Double-Blind Method<br/>Drug Therapy, Combination--methods<br/>Female<br/>Humans<br/>Infant<br/>Male<br/>Pseudomonas Infections--complications<br/>Pseudomonas aeruginosa--drug effects<br/>Recurrence<br/>Time Factors<br/>Tobramycin--administration & dosage<br/>Treatment Outcome